32 Biosciences is a biotechnology company at the forefront of gut microbiome medicine, focusing on both diagnostics and therapeutics.
32 Biosciences has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
32 Biosciences is headquartered in North Chicago, United States.
32 Biosciences is a biotechnology company at the forefront of gut microbiome medicine, focusing on both diagnostics and therapeutics.
32 Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"32 Biosciences — Funding & Investors." VCBacked, June 10, 2025, https://www.vcbacked.co/company/32-biosciences. Accessed October 27, 2026.
VCBacked. (2025). 32 Biosciences — Funding & Investors. Retrieved October 27, 2026, from https://www.vcbacked.co/company/32-biosciences
{{cite web |title=32 Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/32-biosciences |website=VCBacked |access-date=October 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated